Rapidly advancing technologies favor post-MI fibrotic biomarkers identification, such as MMP, collagen peptides, galectin-3, and ST-2 (Bostan et al., 2020), which can be combined with MI biomarkers, such as creatine kinase-myocardial band (CK-MB), troponin, and N-terminal-pro type brain natriuretic peptides (NT-proBNP). This evidence concerns the gene LGALS3 and myocardial infarction.